Hostname: page-component-8448b6f56d-sxzjt Total loading time: 0 Render date: 2024-04-24T12:42:00.458Z Has data issue: false hasContentIssue false
  • English
  • Français

Cognitive and psychiatric effects of vitamin B12 replacement in dementia with low serum B12 levels: a nursing home study

Published online by Cambridge University Press:  17 October 2008

Christopher H. van Dyck ,
Jeffrey M. Lyness ,
Robert M. Rohrbaugh  and
Alan P. Siegal
Christopher H. van Dyck*
Affiliation:
Azheimer's Disease Research Unit, Yale University School of Medicine, New Haven, CT, U.S.A. Department of Psychiatry, Yale University School of Medicine, New Haven, CT, U.S.A. Department of Neurobiology, Yale University School of Medicine, New Haven, CT, U.S.A.
Jeffrey M. Lyness
Affiliation:
Department of Psychiatry, University of Rochester Medical Center, Rochester, NY, U.S.A.
Robert M. Rohrbaugh
Affiliation:
Department of Psychiatry, Yale University School of Medicine, New Haven, CT, U.S.A.
Alan P. Siegal
Affiliation:
Department of Psychiatry, Yale University School of Medicine, New Haven, CT, U.S.A.
*
Correspondence should be addressed to: Christopher H. van Dyck, MD, Alzheimer's Disease Research Unit, Department of Psychiatry, Yale University School of Medicine, One Church Street, Suite 600, New Haven, CT 06510, U.S.A. Phone: +1-203-764-8100; Fax +1-203-764-8111. Email: christopher.vandyck@yale.edu.
Get access Rights & Permissions [Opens in a new window]

Abstract

Background: The aim of this study is to determine whether B12 replacement would ameliorate cognitive and psychiatric symptoms in elderly subjects with dementia and low serum B12 levels.

Methods: A test group (n = 28) of nursing home residents with low serum B12 levels (<250 pg/mL) and a matched comparison group (n = 28) with normal serum B12 levels (>300 pg/mL) were evaluated by blinded raters while the test group received intramuscular (IM) B12 replacement therapy. All subjects were assessed at baseline, 8 weeks, and 16 weeks with the Dementia Rating Scale, Brief Psychiatric Rating Scale, and Geriatric Depression Scale.

Results: Although B12 replacement produced significant improvement in hematologic and metabolic parameters, it yielded no significant effect on cognitive or psychiatric variables. A few subjects evidenced notable individual treatment responses; however, these were not statistically more frequent than in the normal B12 group.

Conclusions: These results suggest that B12 replacement is unlikely to benefit cognitive or psychiatric symptoms in the vast majority of elderly dementia patients with low serum B12 levels.

Keywords

vitamin B12cobalamindementiamethylmalonic acidhomocysteine
Type
Research Article
Information
International Psychogeriatrics , Volume 21 , Issue 1 , February 2009 , pp. 138 - 147
Copyright
Copyright © International Psychogeriatric Association 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Allen, R. H., Stabler, S. P., Savage, D. G. and Lindenbaum, J. (1993). Elevation of 2-methylcitric acid I and II in the serum, urine and cerebrospinal fluid of patients with cobalamin deficiency. Metabolism, 42, 978–988.CrossRefGoogle Scholar
American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised. Washington, DC: American Psychiatric Association.Google Scholar
American Psychiatric Association (2007). Practice guideline for the treatment of patients with Alzheimer's disease and other dementias. American Journal of Psychiatry, 164 (December suppl.), 1–56.Google Scholar
Brink, T. L., Yesavage, J. A., Lum, O., Heersema, P. H., Adey, M. and Rose, T. L. (1982). Screening tests for geriatric depression. Clinical Gerontologist, 1, 37–43.CrossRefGoogle Scholar
Carmel, R., Sinow, R. M. and Karnaze, D. S. (1987). Atypical cobalamin deficiency. Subtle biochemical evidence of deficiency is commonly demonstrable in patients without megaloblastic anemia and is often associated with protein-bound cobalamin malabsorption. Journal of Laboratory and Clinical Medicine, 109, 454–463.Google ScholarPubMed
Carmel, R. et al. (1995). The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities. European Journal of Haematology, 54, 245–253.CrossRefGoogle ScholarPubMed
Cunha, U. G., Rocha, F. L., Peixoto, J. M., Motta, M. F. and Barbosa, M. T. (1995). Vitamin B12 deficiency and dementia. International Psychogeriatrics, 7, 85–88.CrossRefGoogle ScholarPubMed
de la Fournière, F. et al. (1997). Déficience en vitamine B12 et état démentiel: étude épidémiologique multicentrique et thérapeutique. Essai préliminaire. La Semaine des hôpitaux de Paris, 73, 133–140.Google Scholar
Eastley, R., Wilcock, G. K. and Bucks, R. S. (2000). Vitamin B12 deficiency in dementia and cognitive impairment: the effects of treatment on neuropsychological function. International Journal of Geriatric Psychiatry, 15, 226–233.3.0.CO;2-K>CrossRefGoogle ScholarPubMed
Folstein, M. F., Fostein, S. E. and McHugh, P. R. (1975). “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.CrossRefGoogle Scholar
Gottlieb, G. L., Gur, R. E. and Gur, R. C. (1988). Reliability of psychiatric scales in patients with dementia of the Alzheimer type. American Journal of Psychiatry, 145, 857–860.Google ScholarPubMed
Hachinski, V. C. et al. (1975). Cerebral blood flow in dementia. Archives of Neurology, 32, 632–637.CrossRefGoogle ScholarPubMed
Hughes, D., Elwood, P. C., Shinton, N. K. and Wrighton, R. J. (1970). Clinical trial of the effect of vitamin B12 in elderly subjects with low serum B12 levels. BMJ, 2, 458–460.CrossRefGoogle Scholar
Hvas, A. M., Juul, S., Lauritzen, L., Nexo, E. and Ellegaard, J. (2004). No effect of vitamin B-12 treatment on cognitive function and depression: a randomized placebo controlled study. Journal of Affective Disorders, 81, 269–73.CrossRefGoogle ScholarPubMed
Lindenbaum, J. et al. (1988). Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. New England Journal of Medicine, 318, 1720–1728.CrossRefGoogle ScholarPubMed
Lindenbaum, J., Rosenberg, I. H., Wilson, P. W. F., Stabler, S. P. and Allen, R. H. (1994). Prevalence of cobalamin deficiency in the Framingham elderly population. Amereican Journal of Clinical Nutrition, 60, 2–11.CrossRefGoogle ScholarPubMed
Malouf, R. and Areosa Sastre, A. (2003). Vitamin B12 for cognition. Cochrane Database Systematic Review, CD004394.CrossRefGoogle Scholar
Martin, D. C., Francis, J., Protetch, J. and Huff, F. J. (1992). Time dependency of cognitive recovery with cobalamin replacement: report of a pilot study. Journal of the American Geriatrics Society, 40, 168–172.CrossRefGoogle ScholarPubMed
Mattis, S. (1976). Mental status examination for organic mental syndrome in the elderly patient. In Bellack, L. and Karasu, T. B. (eds.), Geriatric Psychiatry (pp. 77–121). New York: Grune & Stratton.Google Scholar
Overall, J. E. and Gorham, D. R. (1962). The brief psychiatric rating scale. Psychological Reports, 10, 799–812.CrossRefGoogle Scholar
Pennypacker, L. C. et al. (1992). High prevalence of cobalamin deficiency in elderly outpatients. Journal of the American Geriatrics Society, 40, 1197–1204.CrossRefGoogle ScholarPubMed
Rasmussen, K., Vyberg, B., Pedersen, K. O. and Brochone-Mortensen, J. (1990). MMA in renal insufficiency: evidence of accumulation and implications for diagnosis of cobalamin deficiency. Clinical Chemistry, 36, 1523–1524.CrossRefGoogle Scholar
Salmon, D. P., Thal, L. J., Butters, N. and Heindel, W. C. (1990). Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standardized mental status examinations. Neurology, 40, 1225–1230.CrossRefGoogle ScholarPubMed
Savage, D. G., Lindenbaum, J., Stabler, S. P. and Allen, R. H. (1994). Sensitivity of serum MMA and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. American Journal of Medicine, 96, 239–246.CrossRefGoogle Scholar
Seal, E. C., Metz, J., Flicker, L. and Melny, J. (2002). A randomized, double-blind, placebo-controlled study of oral vitamin B12 supplementation in older patients with subnormal or borderline serum vitamin B12 concentrations. Journal of the American Geriatrics Society, 50, 146–151.CrossRefGoogle ScholarPubMed
Sheikh, J. I. and Yesavage, J. A. (1986). Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. In Brink, T. L (ed.), Clinical Gerontology: A Guide to Assessment and Intervention (pp. 165–173). New York: Haworth Press.Google Scholar
Stabler, S. P., Marcell, P. D., Podell, E. R., Allen, R. H. and Lindenbaum, J. (1986). Assay of methylmalonic acid in the serum of patients with cobalamin deficiency using capillary gas chromatography-mass spectrometry. Journal of Clinical Investigations, 77, 1606–1612.CrossRefGoogle ScholarPubMed
Stabler, S. P., Marcell, P. D., Podell, E. R., Allen, R. H., Savage, D. G. and Lindenbaum, J. (1988). Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry. Journal of Clinical Investigations, 81, 466–74.CrossRefGoogle ScholarPubMed
Teunisse, S., Bollen, A. E., van Gool, W. A. and Walstra, G. J. M. (1996). Dementia and subnormal levels of vitamin B12: effects of replacement therapy on dementia. Journal of Neurology, 243, 522–529.CrossRefGoogle ScholarPubMed
Thompson, W. G., Babitz, L., Cassino, C., Freedman, M. and Lipkin, M. (1987). Evaluation of current criteria used to measure vitamin B12 levels. American Journal of Medicine, 82: 291–294.CrossRefGoogle ScholarPubMed